Download PDF
Klin Monbl Augenheilkd 2015; 232(11): 1260-1269
DOI: 10.1055/s-0035-1558170
Übersicht
Georg Thieme Verlag KG Stuttgart · New York

Die nicht arteriitische anteriore ischämische Optikusneuropathie (NAION)

Non-Arteritic Ischemic Optic Neuropathy (NAION)
H. Wilhelm
1   Augenheilkunde, Universitätskliniken Tübingen
,
F. Beisse
2   Augenheilkunde, Universitätskliniken Heidelberg
,
K. Rüther
3   Augenarztpraxis, Dorotheenstraße 56, Berlin
› Author Affiliations
Further Information

Publication History

eingereicht 29 July 2015

akzeptiert 07 September 2015

Publication Date:
17 November 2015 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die nicht arteriitische anteriore ischämische Optikusneuropathie (NAION) ist außerhalb der Augenheilkunde nahezu unbekannt. Ihr Merkmal ist eine akute einseitige Sehverschlechterung ohne Augenbewegungsschmerz mit obligater Papillenschwellung. Die Papillenschwellung bildet sich, eine Atrophie hinterlassend, innerhalb 1–2 Monaten zurück, das Sehvermögen bessert sich i. d. R. kaum. Die NAION entsteht mit großer Wahrscheinlichkeit durch das Zusammenwirken lokaler Besonderheiten der Blutversorgung der Sehnervenpapille und allgemeiner vaskulärer Risikofaktoren. Unter diesen Risikofaktoren spielen Diabetes, Hypertonie und vor allem das Schlafapnoe-Syndrom eine wichtige Rolle. Rezidive am betroffenen Auge sind selten, aber am Partnerauge kommt es in ca. 15 % zum Rezidiv. Es gibt keine durch Studien abgesicherte Therapie, aber allgemeinen Konsens, dass die Bekämpfung aller Risikofaktoren sinnvoll ist.

Abstract

Non-arteritic ischemic optic neuropathy (NAION) is virtually unknown outside ophthalmology. It is characterised by acute unilateral visual loss, no pain on eye movements and virtually always optic disc swelling. Optic disc oedema resolves within 1 to 2 months, leaving behind optic atrophy. Vision hardly improves. NAION is the product of local abnormalities of the vascular supply to the optic nerve and general vascular risk factors. Of these, diabetes, hypertension and especially sleep apnoea syndrome are the most important. Recurrences in the involved eye are rare; contralateral recurrence occurs in approximately 15 % of patients. There is no clear scientific evidence for any specific therapy. However, there is general agreement that it is reasonable to control risk factors.

Schlüsselwörter

Sehnerveninfarkt - Riesenzellarteriitis - Schlafapnoe - Neuroophthalmologie

Key words

optic nerve infarction - giant cell arteriitis - sleep apnea - neuroophthalmology
 

  • Literatur

  • 1 Hayreh SS. Anterior Ischemic Optic Neuropathy. Berlin, Heidelberg: Springer; 1975
    CrossrefGoogle Scholar
  • 2 Hayreh SS. Management of ischemic optic neuropathies. Indian J Ophthalmol 2011; 59: 123-136
    PubMedGoogle Scholar
  • 3 Unsöld R. Anteriore ischämische Optikusneuropathie: Ätiologie, Pathogenese und Therapie. Ophthalmologe 2008; 105: 867-882
    CrossrefPubMedGoogle Scholar
  • 4 Hasanreisoglu M, Robenshtok E, Ezrahi D et al. Do patients with non-arteritic ischemic optic neuritis have increased risk for cardiovascular and cerebrovascular events?. Neuroepidemiology 2013; 40: 220-224
    CrossrefPubMedGoogle Scholar
  • 5 Kraus A. Die Bedeutung von Risikofaktoren und assoziierten Erkrankungen bei vorderer ischämischer Optikusneuropathie [Dissertation]. Tübingen: Medizinische Fakultät der Eberhard-Karls-Universität; 1993
    PubMedGoogle Scholar
  • 6 Guyer DR, Miller NR, Auer CL et al. The risk of cerebrovascular and cardiovascular disease in patients with anterior ischemic optic neuropathy. Arch Ophthalmol 1985; 103: 1136-1142
    CrossrefPubMedGoogle Scholar
  • 7 Talks SJ, Chong NH, Gibson JM et al. Fibrinogen, cholesterol and smoking as risk factors for non-arteritic anterior ischaemic optic neuropathy. Eye (Lond) 1995; 9: 85-88
    CrossrefPubMedGoogle Scholar
  • 8 Hayreh SS, Jonas JB, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy and tobacco smoking. Ophthalmology 2007; 114: 804-809
    CrossrefPubMedGoogle Scholar
  • 9 Lee MS, Grossman D, Arnold AC et al. Incidence of nonarteritic anterior ischemic optic neuropathy: increased risk among diabetic patients. Ophthalmology 2011; 118: 959-963
    CrossrefPubMedGoogle Scholar
  • 10 Bilgin G, Koban Y, Arnold AC. Nonarteritic anterior ischemic optic neuropathy and obstructive sleep apnea. J Neuroophthalmol 2013; 33: 232-234
    CrossrefPubMedGoogle Scholar
  • 11 Mojon DS, Hedges 3rd TR, Ehrenberg B et al. Association between sleep apnea syndrome and nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol 2002; 120: 601-605
    CrossrefPubMedGoogle Scholar
  • 12 Palombi K, Renard E, Levy P et al. Non-arteritic anterior ischaemic optic neuropathy is nearly systematically associated with obstructive sleep apnoea. Br J Ophthalmol 2006; 90: 879-882
    CrossrefPubMedGoogle Scholar
  • 13 Stein JD, Kim DS, Mundy KM et al. The association between glaucomatous and other causes of optic neuropathy and sleep apnea. Am J Ophthalmol 2011; 152: 989-998.e3
    CrossrefPubMedGoogle Scholar
  • 14 Campbell UB, Walker AM, Gaffney M et al. Acute nonarteritic anterior ischemic optic neuropathy and exposure to phosphodiesterase type 5 inhibitors. J Sex Med 2015; 12: 139-151
    CrossrefPubMedGoogle Scholar
  • 15 Mindel JS, Anderson J, Hellkamp A et al. Absence of bilateral vision loss from amiodarone: a randomized trial. Am Heart J 2007; 153: 837-842
    CrossrefPubMedGoogle Scholar
  • 16 Passman RS, Bennett CL, Purpura JM et al. Amiodarone-associated optic neuropathy: a critical review. Am J Med 2012; 125: 447-453
    CrossrefPubMedGoogle Scholar
  • 17 Hayreh SS. Anterior ischemic optic neuropathy. IV. Occurrence after cataract extraction. Arch Ophthalmol 1980; 98: 1410-1416
    CrossrefPubMedGoogle Scholar
  • 18 Newman NJ. Perioperative visual loss after nonocular surgeries. Am J Ophthalmol 2008; 145: 604-610
    CrossrefPubMedGoogle Scholar
  • 19 Beck RW, Savino PJ, Repka MX et al. Optic disc structure in anterior ischemic optic neuropathy. Ophthalmology 1984; 91: 1334-1337
    CrossrefPubMedGoogle Scholar
  • 20 Beck RW, Savino PJ, Repka MX et al. Structural factors in the pathogenesis of ischemic optic neuropathy. Am J Ophthalmol 1984; 98: 649-650
    PubMedGoogle Scholar
  • 21 Beck RW, Servais GE, Hayreh SS. Anterior ischemic optic neuropathy. IX. Cup-to-disc ratio and its role in pathogenesis. Ophthalmology 1987; 94: 1503-1508
    CrossrefPubMedGoogle Scholar
  • 22 Jonas JB, Xu L. Optic disc morphology in eyes after nonarteritic anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci 1993; 34: 2260-2265
    PubMedGoogle Scholar
  • 23 Mansour AM, Shoch D, Logani S. Optic disk size in ischemic optic neuropathy. Am J Ophthalmol 1988; 106: 587-589
    CrossrefPubMedGoogle Scholar
  • 24 Gerling J, Janknecht P, Hansen LL et al. Diameter of the optic nerve in idiopathic optic neuritis and in anterior ischemic optic neuropathy. Int Ophthalmol 1997; 21: 131-135
    CrossrefPubMedGoogle Scholar
  • 25 Wiek J, Funk J, Hansen LL. Computergesteuerte Papillenanalyse bei Patienten mit anteriorer ischämischer Optikusneuropathie (AION). Klin Monatsbl Augenheilkd 1995; 206: 92-95
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Purvin V, King R, Kawasaki A et al. Anterior ischemic optic neuropathy in eyes with optic disc drusen. Arch Ophthalmol 2004; 122: 48-53
    CrossrefPubMedGoogle Scholar
  • 27 Newman WD, Dorrell ED. Anterior ischemic optic neuropathy associated with disc drusen. J Neuroophthalmol 1996; 16: 7-8
    PubMedGoogle Scholar
  • 28 Lam BL, Jabaly-Habib H, Al-Sheikh N et al. Risk of non-arteritic anterior ischaemic optic neuropathy (NAION) after cataract extraction in the fellow eye of patients with prior unilateral NAION. Br J Ophthalmol 2007; 91: 585-587
    CrossrefPubMedGoogle Scholar
  • 29 Landau K, Winterkorn JM, Mailloux LU et al. 24-hour blood pressure monitoring in patients with anterior ischemic optic neuropathy. Arch Ophthalmol 1996; 114: 570-575
    CrossrefPubMedGoogle Scholar
  • 30 Hayreh SS, Podhajsky PA, Zimmerman B. Ipsilateral recurrence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 2001; 132: 734-742
    CrossrefPubMedGoogle Scholar
  • 31 Hayreh SS, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome. Ophthalmology 2008; 115: 298-305.e2
    CrossrefPubMedGoogle Scholar
  • 32 Arida A, Kyprianou M, Kanakis M et al. The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis. BMC Musculoskelet Disord 2010; 11: 44
    CrossrefPubMedGoogle Scholar
  • 33 Czihal M, Forster S, Hoffmann U. Bildgebende Diagnostik der Großgefäßvaskulitis. Radiologe 2010; 50: 855-860
    CrossrefPubMedGoogle Scholar
  • 34 Januschowski K, Wilhelm H. Vom Risiko, die Diagnose einer Arteriitis temporalis zu versäumen. Klin Monatsbl Augenheilkd 2012; 229: 1079-1082
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Kermani TA, Schmidt J, Crowson CS et al. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum 2012; 41: 866-871
    CrossrefPubMedGoogle Scholar
  • 36 Yoeruek E, Szurman P, Tatar O et al. Anterior ischemic optic neuropathy due to giant cell arteritis with normal inflammatory markers. Graefes Arch Clin Exp Ophthalmol 2008; 246: 913-915
    CrossrefPubMedGoogle Scholar
  • 37 Hayreh SS, Zimmerman MB. Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1029-1046
    CrossrefPubMedGoogle Scholar
  • 38 The Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA 1995; 273: 625-632
    CrossrefPubMedGoogle Scholar
  • 39 Dickersin K, Manheimer E, Li T. Surgery for nonarteritic anterior ischemic optic neuropathy. Cochrane Database Syst Rev 2012; (1) CD001538
    PubMedGoogle Scholar
  • 40 Rebolleda G, Perez-Lopez M, Casas-Llera P et al. Visual and anatomical outcomes of non-arteritic anterior ischemic optic neuropathy with high-dose systemic corticosteroids. Graefes Arch Clin Exp Ophthalmol 2013; 251: 255-260
    CrossrefPubMedGoogle Scholar
  • 41 Biousse V, Newman NJ. Ischemic Optic Neuropathies. N Engl J Med 2015; 372: 2428-2436
    CrossrefPubMedGoogle Scholar
  • 42 Radoi C, Garcia T, Brugniart C et al. Intravitreal triamcinolone injections in non-arteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol 2014; 252: 339-345
    CrossrefPubMedGoogle Scholar
  • 43 Ganssauge M, Wilhelm H, Bartz-Schmidt KU et al. Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin) for treatment of angoid streaks in pseudoxanthoma elasticum. Graefes Arch Clin Exp Ophthalmol 2009; 247: 1707-1710
    CrossrefPubMedGoogle Scholar
  • 44 Kalenak JW, Kosmorsky GS, Rockwood EJ. Nonarteritic anterior ischemic optic neuropathy and intraocular pressure. Arch Ophthalmol 1991; 109: 660-661
    CrossrefPubMedGoogle Scholar
  • 45 Wilhelm B, Ludtke H, Wilhelm H. Efficacy and tolerability of 0.2 % brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): a 3-month, double-masked, randomised, placebo-controlled trial. Graefes Arch Clin Exp Ophthalmol 2006; 244: 551-558
    CrossrefPubMedGoogle Scholar
  • 46 Newman NJ, Scherer R, Langenberg P et al. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol 2002; 134: 317-328
    CrossrefPubMedGoogle Scholar
  • 47 Sanderson M, Kupersmith M, Frohman L et al. Aspirin reduces anterior ischemic optic neuropathy (AION) in the 2nd eye. Invest Ophthalmol Vis Sci 1995; 36: S196
    PubMedGoogle Scholar
  • 48 Beck RW, Hayreh SS, Podhajsky PA et al. Aspirin therapy in nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1997; 123: 212-217
    CrossrefPubMedGoogle Scholar
  • 49 Beck RW, Hayreh SS. Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy. Eye (Lond) 2000; 14: 118
    CrossrefPubMedGoogle Scholar